2. Operation/Project Warp Speed was invented by Peter Marks (a star trekkie) to streamline and accelerate the path to a successful vaccine
More on that here washingtonpost.com/health/coronav… by @lauriemcginley2
3. Why didn't the vaccine trials study transmission (mucosal impact/ sterilization immunity)?
The requirement of the participants for daily nasopharyngeal swabs would have been cumbersome and slowed down the trial's critical question of preventing illness
4. Why did the UK wind up approving a vaccine first, ~10 days earlier?
"We did not see this as a competition"
The need to do it right, fully transparent, fully vetted before rolling it out to millions of Americans. It took <3 wks for each of the vaccines to go thru this process.
5. What about single-dose of the vaccines since there was a sign of some efficacy after ~10 days?
"I understand the temptation.... But...We did really good science." Don't throw it out.
"One [dose] could be worse than none."
"Good to study but don't do it."
"Not responsible."
6. What about the new variant (B.1.1.7) w/ its 23 mutations? And N501Y?
Do we need do to big clinical trials again for tweaking the mRNA vaccines (booster shots)?
"Starting to look like son of flu or father of flu" w/r to evolution
Just needs small trials for immune response
7. What is the culprit for extremely rare allergic reactions?
Could be IgE antibodies to the polyethylene glycol but don't know yet, incidence may be ~1 in 100,000.
8. What about the the people in the trials who actually had prior covid-19?
—No evidence of antibody-dependent enhancement
—Wait 90 days after covid-19 infection or after receiving antibodies
—The look of superior protection by vaccine than via natural infection
9. What are the major unsettled vaccine questions or ones that keep you up at night?
—Do the vaccines stop asymptomatic transmission?
—How long does the protection last?
—How will they handle the drift/mutation changes in the virus?
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Countries the B.1.1.7 variant has been found in:
UK, Denmark, Singapore, Australia, Netherlands, Sweden, Spain, Switzerland, Lebanon, France, Israel, Italy.
Hard to imagine it has not reached US by this time
Add: Japan, Iceland, Belgium, Germany
Now add Ontario, Canada in a couple with no history of travel
We've now doubled the peak hospitalizations from the previous 2 US case surges.
And it's no wonder the death toll again today is nearly 3,500. @COVID19Tracking
Sure the virus is hard to contain, but that's especially the case when so little is being done
The @HHSgov declared covid as a public health emergency on Jan 31st
And @WhiteHouse a national emergency March 13th whitehouse.gov/presidential-a…
If that was emergency, then what is this?
The actions we could take beyond financial support that still has not been approved......
1. Distribute high quality (surgical or K/N95) masks to all households [@USPS planned 650 million distribution in April, blocked by @WhiteHouse] 2. Make mask mandates a national policy with enforcement 3. Provide free rapid home covid tests to all households for daily use
1. Structural biology has been a standout in the pandemic, mapping the virus, antibodies and vaccines atom by atom. So I had a conversation with one of its leaders, Andrew Ward @WardLab1, my @scrippsresearch colleague soundcloud.com/prescrippsions…
2. Back in 2016, Andrew and his colleagues were the first to see and publish the coronavirus spike protein, via cryo-electron microscopy (a common cold virus, HKU1) nature.com/articles/natur…@nature
Note the team, which proved to be formidable @McLellan_Lab@KizzyPhD Barney Graham
3. In the podcast, Andrew reviews how they came together. A next act was the famous 2P (2 proline substitutions) paper that was rejected 5 times before being published @PNASNews
Subthread about that here:
The B.1.1.7 variant has 23 mutations
I spoke to Andrew Ward (@WardLab1) @ScrippsResearch today (podcast coming) about its structural biology. He thinks the N501Y (in common w/ South Africa variant) is the driver for increased transmission; he's not concerned re: vaccine efficacy
On @CNN@wolfblitzer, @NYGovCuomo just said the new variant transmits 70-fold the D614G and that it accounted for Europe’s 2nd wave. Both are wrong!
While the B.1.1.7 variant is thought to have been derived from accelerated evolution in an immunocompromised patient with covid (see examples in these 2 @NEJM reports), if the functional culprit is indeed N501Y, that might turn out to be a red herring
1. There are limited data about the vaccines for people who have had covid. But we can learn from the @Pfizer@BioNTech and @moderna trials which had 3% and 2.2% participants respectively confirmed at baseline (via FDA briefing docs)
2. In the Pfizer trial there were 9 reinfections among 670 participants (1.3%) who received placebo which was the same rate as those without prior infection (259 of 19,818 participants, 1.3%).
Only 1 reinfection in the vaccine group (after ≥ 7 days) for those w/ prior infection
3. We need to learn more about this with so many people with prior infections getting vaccinated. But this finding suggests vaccine-induced immune response may add protection to the natural response and adds another layer to the superhuman concept 👇